Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026)
Neurocrine Biosciences (NBIX) recorded Intangibles of $2.23 billion in Q2 2026, compared with $37.2 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences reported Intangibles of $4.7 million, down 87.1% from FY2024.
- Annual Intangibles has a three-year compound annual growth rate of -49.8% (FY2022 to FY2025).
- Across earlier years, Intangibles came in at $36.5 million in FY2024 (+2.8%), $35.5 million in FY2023 (-4.6%) and $37.2 million in FY2022.
- The Q2 2026 figure is the highest quarterly Intangibles in data going back to Q4 2022.
- On a year-over-year basis, Intangibles rose in four of the last six quarters, with an average decline of 10.8%.
- Peak year-over-year performance for Intangibles in the last five years was growth of 11.0% in Q2 2025, against a decline of 87.1% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 2.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Bn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 35.70 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 36.50 Mn |
| Sep 30, 2024 | 34.50 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 34.30 Mn |
| Dec 31, 2023 | 35.50 Mn |
| Sep 30, 2023 | 34.90 Mn |
| Jun 30, 2023 | 36.90 Mn |
| Mar 31, 2023 | 37.20 Mn |
| Dec 31, 2022 | 37.20 Mn |
API Access
Neurocrine Biosciences Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();